Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00541164 · ClinicalTrials.gov registry record · Phase 1
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
A Phase 1 study, sponsored by Memorial Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00541164 is a Phase 1 study that has completed, run by Memorial Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT00541164, a Phase 1 study, has completed, sponsored by Memorial Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The object of this research is to test the effectiveness of Coenzyme Q10 (CoQ10) on symptoms of weakness, fatigue, and pain in persons with Charcot-Marie-Tooth disease (CMT).In this study we also intend to examine the impact of daily supplementation on overall quality of life.We are also interested in identifying any differences in serum ratios of CoQ10 in the oxidized and reduced forms.
Interventions
- DIETARY_SUPPLEMENT Coenzyme Q10
- DRUG Coenzyme Q10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00541164
The ClinicalTrials.gov registry entry for NCT00541164 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Coenzyme Q10 is the first listed.
NCT00541164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00541164 about?
NCT00541164 is a clinical study titled "Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease". The object of this research is to test the effectiveness of Coenzyme Q10 (CoQ10) on symptoms of weakness, fatigue, and pain in persons with Charcot-Marie-Tooth disease (CMT).In this study we also intend to examine the impact of daily supplementation on overall quality of life.We are also interested ...
What is the current status of trial NCT00541164?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2007-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00541164?
The interventions under investigation include: Coenzyme Q10 (DIETARY_SUPPLEMENT), Coenzyme Q10 (DRUG).
Who is sponsoring clinical trial NCT00541164?
This trial is sponsored by Memorial Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.